Form 4: CVRx, Inc. Executive Philip B. Adamson Reports Acquisition of Stock and Stock Options

Philip B. Adamson, Chief Medical Officer of CVRx, Inc., reports the acquisition of 20,000 shares of common stock and options to purchase 30,000 shares.

Summary

• On February 28, 2025, Philip B. Adamson, Chief Medical Officer of CVRx, Inc., acquired 20,000 shares of common stock.
• These shares were acquired at a price of $0.
• Adamson also acquired options to purchase 30,000 shares of common stock at an exercise price of $12.96.
• These options vest as to 25% of the shares on February 28, 2026, and then as to 1/48th of the shares each month thereafter.
• The options expire on February 27, 2035.
• Following these transactions, Adamson directly owns 20,000 shares of common stock and options to purchase 30,000 shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of shares and options by an executive is generally viewed as a positive sign, but it's not overwhelmingly so.

Positives

• The acquisition of shares and options by a key executive could be interpreted as a positive signal regarding their confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and alignment with shareholder interests.

Stakeholder Impact

• Shareholders may view the insider's stock acquisition as a positive signal.

Key Dates